NIH Reporter #5F31AR085942-02

NIAMS grant for CDK8 inhibition research in ischemic fracture healing

This opportunity from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports research on CDK8 inhibition for ischemic fracture healing at the University of Michigan. - Government Buyer: - National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - Research conducted at University of Michigan, Department of Orthopedics - Products/Services Requested: - Research and development activities focused on CDK8 inhibition as a therapeutic intervention - 1 unit of research and development (no specific part number) - OEMs and Vendors: - No specific OEMs or commercial vendors mentioned; this is a research grant - Notable Requirements: - Emphasis on innovative therapeutic approaches for improving fracture healing under ischemic conditions - Opportunity classified under NAICS codes 237110 and 541712 - Estimated contract value: $45,426 - No specific equipment or commercial products required; focus is on scientific research

Description

This NIH grant opportunity focuses on research and development activities related to CDK8 inhibition as a therapeutic intervention for ischemic fracture healing. The project is funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and conducted at the University of Michigan at Ann Arbor, Department of Orthopedics. The funding amount is $45,426 for the period from June 1, 2026, to May 31, 2027. The application deadline is June 11, 2026.

View original listing